𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA Ploidy, Bromodeoxyuridine labelling index, S-phase fraction and AgNOR counts in brain tumours

✍ Scribed by Gasińska Anna; Niemiec Joanna; Adamczyk Agnieszka

Book ID
104440943
Publisher
Wielkopolskie Centrum Onkologii
Year
2000
Tongue
Polish
Weight
592 KB
Volume
5
Category
Article
ISSN
1507-1367

No coin nor oath required. For personal study only.

✦ Synopsis

DNA ploidy and the proliferative potential in 88 brain tumours were investigated using the bromodeoxyuridine labelling index (BrdUrd L1), S -phase fraction (SPF) and an argyrophilic nucleolar organizer regions (AgNOR) technique. The study included 65 highly malignant (Alii -AIV), and 23 low-grade (AI -All) gliomas. One fragment of the tumour was fixed in Carnoy's solution for AgNOR test, while the other fragments were used for flow cytometric determination of the labelling index, SPF and DNA ploidy. For the BrdUrdLl, tumour samples from each patient were incubated in vitro for one hour at 37 0 C with BrdUrd using a high pressure oxygen method. After fixation and staining, the percentages of BrdUrd-labelied cells (BrdUrdLl) and unlabelled S-phase cells (SPF) were evaluated. The tumours showed variability in the BrdUrdLi values, SPF and AgNOR counts/cell nucleus. However, grade dependent differences in the proliferating rate were only found to exist on the basis of BrdUrdLi and AgNOR counts. The same percentage of DNA aneuploidy (56 %) was found in high-grade as well as in lowgrade gliomas. A linear -regression analysis showed a significant correlation between the results of three applied methods: BrdUrdLl, SPF and AgNOR counts.

📜 SIMILAR VOLUMES

Relationship of Ki-67 labeling index to
Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy
✍ Khoo, Vincent S.; Pollack, Alan; Cowen, Didier; Joon, Daryl Lim; Patel, Nalini; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

## BACKGROUND. Our purpose was to evaluate the relationship of Ki-67 labeling index (Ki67-LI) to deoxyribonucleic acid (DNA) ploidy, S phase fraction (SPF), other clinical prognostic factors, and clinical outcome for patients with prostate cancer treated by external beam radiotherapy. METHODS. Tis

S-phase fraction, 5-bromo-2′-deoxy-uridi
S-phase fraction, 5-bromo-2′-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors
✍ H. Struikmans; D.H. Rutgers; G.H. Jansen; C.A.F. Tulleken; I. van der Tweel; J.J 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Seventy-one histologically malignant brain tumors, 52 histologically benign brain tumors, and 14 cerebral metastases were characterized according to DNA content and proliferative capacity. DNA ploidy, DNA index (DI), S-phase fraction (SPF), 5-bromo-2'-deoxy-uridine (BrdUrd) labelling index (LI), dur